Showing results (1-10 of 1,368) with videos related to
Sort By:
Pageof 137
Clinical Pharmacology and Therapeutics|May 1, 1975
Lack of effect of rheumatoid arthritis on clonixin metabolismD E Furst, H E PaulusThe Journal of Clinical Investigation|July 1, 1977
Salicylate metabolism in twins. Evidence suggesting a genetic influence and induction of salicylurate formationD E Furst, N Gupta, H E PaulusJournal of Pharmaceutical Sciences|November 1, 1984
Metabolism of salsalate in normal subjectsS H Dromgoole, D E Furst, H E PaulusClinical Pharmacokinetics|March 1, 1986
Clinical pharmacokinetics of oral and injectable gold compoundsK L Blocka, H E Paulus, D E FurstClinical Pharmacology and Therapeutics|October 1, 1983
Availability of salicylate from salsalate and aspirinS H Dromgoole, S Cassell, D E Furst, et al.Journal of Clinical Pharmacology|July 1, 1983
Clinical pharmacology of tolmetin: comparisons in rheumatoid arthritis patients and normal volunteersD E Furst, S H Dromgoole, R K Desiraju, et al.Biopharmaceutics & Drug Disposition|May 1, 1988
Changes in salicylate serum concentration and metabolism during chronic dosing in normal volunteersR O Day, D E Furst, S H Dromgoole, et al.The Journal of Rheumatology|June 1, 1984
Case control study of antibodies to ENA in progressive systemic sclerosis patientsD E Furst, M Obrodovic, E V Barnett, et al.Annals of the Rheumatic Diseases|December 1, 1984
Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease durationD E Furst, P J Clements, M Saab, et al.Journal of Pharmaceutical Sciences|September 1, 1981
Formation of methyl ester of salicyluric acid during quantitation of salicyluric acid in urine by high-pressure liquid chromatographyR O Day, S H Dromgoole, D E Furst, et al.Pageof 137